October 27, 2025 · Form 4 insider transaction
MCCORMICK FRANK sold 1,641 shares of BridgeBio Pharma, Inc. at $65.00 per share, a transaction worth $106.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 28, 2024.